Mirai Clinical is a startup offering purifying and deodorizing solutions for all ages, leveraging Japanese Persimmon. The company introduces beauty secrets from Japan, rooted in the holistic principle of "less is more." With an international team of experienced skincare and medical professionals from Japan and the U.S., its mission is to develop groundbreaking, naturally safe, and highly effective products for skin health. Founder and CEO Koko Hayashi, raised in Japan, was inspired to launch Mirai Clinical after witnessing the excessive use of synthetic skincare products in the U.S. The company aims to share lesser-known Japanese beauty secrets globally. Mirai Clinical operates in the industries of consumer goods, e-commerce, healthcare, and wellness beauty. Founded in 2009, it is a promising venture with potential for growth and innovation in the global skincare market. Although specific details about the headquarters, recent investment, and investors are unavailable, the company's unique approach to skincare and its culturally rooted philosophy make it an intriguing prospect for potential investors.
There is no investment information
No recent news or press coverage available for Mirai Clinical.